Vita Protocol is bringing healthcare into the Web3 era.
Instead of letting big institutions control health data, Vita gives that power back to users. You decide how your data is used, and you can even earn rewards by supporting medical research.
It’s a simple idea with a big impact: better privacy, more transparency, and a fairer future for healthcare powered by blockchain
Funds Raised & Financial Position
Total funding raised: VitaDAO has raised roughly $8.9M+ in total through token sales and private rounds (including IDO and private sale) according to on-chain funding data.
In January 2023, VitaDAO secure
d a $4.1M funding round from strategic investors.
VitaDAO’s treasury (in assets, research tokens, IP-NFTs, etc.) is reported to be significant — tens of millions of dollars, with some estimates of $55M+ in assets including tokens and intellectual property assets. �
Who’s Backing Them
Major institutional and strategic backers:
Pfizer Ventures – the venture arm of pharmaceutical giant Pfizer (with both financial investment and active participation in governance).
Shine Capital – early investor in VitaDAO rounds.
L1 Digital (L1D) – crypto investment firm.
Crypto & DeSci backers:
Balaji Srinivasan – former Coinbase CTO and notable Web3 angel investor.
BeakerDAO and SpaceshipDAO – decentralized science/community DAOs participating in funding rounds.
Vitalik Buterin (Ethereum co-founder) has been associated with supporting and engaging with the DeSci ecosystem around VitaDAO historically.
